Given the central role of COX-2 in numerous chronic inflammatory and neoplastic diseases, including rheumatoid arthritis, inflammatory bowel disease, and various cancers, the lead compounds identified here may serve as versatile scaffolds for developing multi-target or multi-disease agents. This evidence concerns the gene PTGS2 and inflammatory bowel disease.